3Moore N,Thiessard F, Begaud B.The history of disproportionality measures (reporting odds ratio, proportional reporting rates) in spontaneous reporting of adverse drug reactions[J]. Pharmacoepidemiol Drug Saf, 2005,14 (4) :285.
4Finny DJ. Systematic signalling of adverse reactions to drugs [J]. Meth Inf Med, 1974,13:1.
5Edwards IR, Lindquist M, Wiholm BE, et al. Quality criteria for early signals of possible adverse drug reactions [ J ]. Lancet, 1990,336 ( 8708 ) : 156.
6Hauben M, Zhon XF. Quantitative methods in pharmacogilance: focus on signal detection[J]. Drug Saf,2003,26 (3) : 159.
7Evans SJW, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports [J]. Pharmacoepidemiol Drug Saf,2001,10(6) :483.
8Frederick MS, Andrew JC. An evaluation of potential signals for ventricular arrhythmia and cardiac arrest with dolasetron, ondansetron and granisetron in the FDA combined spontaneous reporting system/adverse event reporting system [ J]. Curr Ther Res,2005,66(5) :409.
9Nakamura T, Sasaki H, Nagai K, et al. Influence of cyclosporin on steroid-induced cataracts after renal transplantation[J]. Ophthalmol, 2003,47(3) :254.
10Matsunami C,Hilton AF, Dyer JA,et al. Ocular complications in renal transplant patients[J]. Aust N Z J Ophthalmol, 1994,22 ( 1 ) :53.
